Article Details

Eli Lilly and Company (LLY) intends to increase sales of immunological illness medications

Retrieved on: 2022-06-22 12:01:59

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly and Company (LLY) intends to increase sales of immunological illness medications. View article details on hiswai:

Excerpt

The most recent advancements made by Eli Lilly and Company (LLY) in the treatment of immunological disorders use monoclonal antibodies.

Article found on: stocksregister.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up